INSIGHTS ON ENTERPRISE SOLUTIONS
-
![pharma-manufacturing-reg-GettyImages-1409457755]( "Improvements In ADC Efficacy And Stability")
Improvements In ADC Efficacy And StabilityAntibody-drug conjugates combine targeted antibodies with potent cytotoxic payloads, but increasing hydrophobicity challenges stability, manufacturability, and pharmacokinetics, driving interest in hydrophilic linker strategies to improve performance.
-
![ElevateBio_BaseCamp_Pittsburgh]( "Building On Pittsburgh's Legacy To Industrialize Advanced Therapies")
Building On Pittsburgh's Legacy To Industrialize Advanced TherapiesPittsburgh's industrial roots and growing biotech hub unite to scale advanced therapies through new purpose‑built biomanufacturing, automation, and workforce development.
-
![cdmo-toxic-fda-GettyImages-2226399886]( "Why Manufacturing Drives FDA CRLs In Cell Therapy")
Why Manufacturing Drives FDA CRLs In Cell TherapyManufacturing and quality gaps drive most FDA Complete Response Letters in cell therapy, often stemming from early‑stage decisions and unresolved CMC issues that become major late‑stage approval risks.
-
![cdmo-toxic-fda-GettyImages-2226399886]( "10 Questions To Ask When Choosing A Cell Therapy CDMO")
10 Questions To Ask When Choosing A Cell Therapy CDMOA strategic framework outlines ten critical questions to evaluate a manufacturing partner’s reliability, expertise, performance, and operational rigor to ensure successful, scalable cell‑therapy development.
-
A Faster Path To Genomic Medicine Feasibility3/17/2026
Life Edit accelerates genomic medicine by comparing five editing modalities, engineering new enzymes, and rapidly pinpointing optimal strategies that boost feasibility, cut risk, and speed clinical progress.
-
High‑Throughput Automation For Consistent Expression3/17/2026
A high‑throughput, automated RNA‑seq workflow maintains uniform gene‑expression profiles across wide RNA inputs, enabling consistent library quality and scalable genomics on standard liquid‑handling platforms.
-
Advanced Characterization Of Engineered T Cells3/17/2026
Single‑cell sequencing and flow cytometry jointly profile engineered T‑cell products, revealing composition, function, and safety attributes to guide therapy platform development and quality control.
-
Large Molecule Capabilities Overview: Large CDMO Strength, Small CDMO Agility3/17/2026
How a seasoned development and manufacturing team blends technical depth, reliability, and flexible support to advance large‑molecule programs amid shifting timelines, costs, and regulatory demands.
ENTERPRISE SOLUTIONS
-
![GettyImages-2189138619 lab]( "Protein Degraders: From Discovery To Development")
Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.
-
![sterile-injection-capsules]( "Pfizer Puurs: Sterile Injectables")
Whether supporting established medicines or accelerating the launch of innovative treatments, the Puurs site delivers the scale, speed, and supply security needed to bring critical therapies to the patients who need them most.
-
![GettyImages-1964958878 glucose monitor wearables patient doctor]( "Putting More Within Reach")
A wearable subcutaneous injector is being developed to support delivery of large‑volume, complex biologic therapies, expanding options for patients needing advanced at‑home administration.
-
![GettyImages-2098817477-vaccine-needle-syringe-gloved-hands-laboratory]( "BD Neopak™ XtraFlow™ Glass Prefillable Syringe")
A next‑generation injectable system uses shorter, thinner needles to reduce injection risk, lower force and time requirements, and improve comfort and usability for administering viscous formulations.
-
![VERSAWELD™]( "A Compact System That Delivers Sterile Tube Connections")
Discover a compact, cordless system that delivers fast, sterile tube connections across multiple materials and sizes. Its long-lasting ribbon design reduces consumables while supporting reliable welds.
